Bork et al. Tig vol. 12, No. 10, pp. 425-427, Oct. 1996.* |
Doerks et al. Tig vol. 14, No. 6, pp. 248-250, Jun. 1998.* |
Brenner et al. Tig vol.15, No. 8, pp. 132-133, Apr. 1999.* |
Vilcek, Jan et al., Immunology of Cytokines The Cytokine Handbook Academic Press, Copyright 1991, Chapter 1, pp. 1-17. |
Shaw, Alan R., “Molecular Biology of Cytokines” The Cytokine Handbook, Academic Press, Copyright 1991, Chapter 2, pp. 20-46. |
Banchereau, Jacques, “Interleukin-4” The Cytokine Handbook, Academic Press, Copyright 1991, Chapter 6, pp. 120-148. |
Schall, Thomas J., “The Chemokines” The Cytokine Handbook, Academic Press, 1994, Sep. 19-20, Second Edition, pp. 180-272. |
Uhlmann et al., “Antisense Oligonucleotides: a New Therapeutic Principle” Chemical Reviews 90(4) : 554-584 (1990). |
Cotten et al., “Ribozyme Mediated Destruction of RNA in vivo” The EMBO Journal 8(12) : 3861-3866 (1989). |
Ledley, F. D., “Clinical Consideration in the Design of Protocols for Somatic Gene Therapy” Human Gene Therapy 2 : 77-82 (1991). |
Anderson, W.F., “Prospects for Human Gene Therapy” Science 226 : 401-409 (1984). |
Opdenakker et al., “The Human MCP-3 Gene (SCYA7) : Cloning, Sequence Analysis, and Assignment to the C-C Chemokine Gene Cluster on Chromosome 17q11.2-q12” Genomics 21 : 403-408 (1994). |
Diamond et al., “Novel delayed-early and highly insulin-induced growth response genes. Indentification of HRS, a potential regulator of alternatives pre-mRNA splicing” Journal of Biol. Chem. 268 (20) : 15185-15192 (1993). |
Derynck et al., (1990) Biochemistry vol. 29, pp. 10225-10233. |